1769
|
T 1776Na
|
Inhibitor of plasminogen activator inhibitor-1 |
€90.00 |
1270
|
T 98475
|
GnRH or LHRH antagonist |
Inquire |
2754
|
T0901317
|
Liver X receptor (LXR) agonist |
€75.00 |
2721
|
T56-LIMKi
|
LIM Kinase 2 (LIMK2) inhibitor |
€125.00 |
2516
|
Tacalcitol
|
Vitamine D receptor (VDR) agonist with antitumor activity |
€165.00 |
2263
|
Tacrolimus
|
Potent Calcineurin (Ca2+ dependent protein phosphatase 2B) inhibitor |
€100.00 |
2399
|
TAK 063
|
Highly potent, selective, and orally active PDE10A inhibitor |
€125.00 |
2053
|
TAK 165
|
ErbB2/HER2 kinase inhibitor |
€65.00 |
2579
|
TAK 259
|
Selective and orally active α1D adrenoceptor antagonist |
€95.00 |
1971
|
TAK 438
|
Potassium-competitive acid blocker (P-CAB) |
€145.00 |
2124
|
TAK 700
|
Potent and highly selective inhibitor of 17,20-lyase (CYP17A1) |
€105.00 |
2502
|
Talazoparib
|
Potent, selective, and orally available PARP1/2 inhibitor |
€105.00 |
1960
|
Tariquidar
|
Inhibitor of P-glycoprotein (P-gp, ABCB1) |
€135.00 |
2914
|
TAS-103 dihydrochloride
|
Dual inhibitor of topoisomerase I (Topo 1) and topoisomerase II (Topo 2) |
€95.00 |
2927
|
Taselisib
|
PI3K inhibitor (p110 β sparing) |
€90.00 |